EUVIMEDEUVIMED entdecken
Multizentrische Studie

Deep integration of clinical metadata with [18F]FDG PET/CT imaging for histological subtyping in non-small cell lung cancer: a multi-center study

Jucheng Zhang, Xiaohui Zhang, Jing Wang, Han Hao, Daoyan Hu, Kangjun Hu, Xuena Li, Yaming Li, Guanghui Liu, Rong Tian, Weiming Wu, Xiaofen Ma und 5 weitere

European Journal of Nuclear Medicine and Molecular Imaging · 2026

DOI: 10.1007/s00259-026-08010-1 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift European Journal of Nuclear Medicine and Molecular Imaging, 2026. Verfasst von Jucheng Zhang und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Engineering, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, 310009, China. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Fluorodeoxyglucose F18, Positron Emission Tomography Computed Tomography, Lung Neoplasms. Die Arbeit nennt 33 Literaturangaben. Gefördert von: Key Technologies Research and Development Program, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: To develop and validate a multimodal deep learning framework that integrates clinical metadata with [18F]FDG PET/CT imaging to resolve overlapping metabolic phenotypes. The primary objective is the histological subtyping of non-small cell lung cancer (NSCLC), utilizing binary clinical staging (early vs. advanced) strategically as an auxiliary regularization task. METHODS: A multi-center surgical NSCLC cohort (n = 780) was partitioned into a development set (n = 675) and an independent external test set (n = 105). The framework first utilized a 3D Transformer for bounding-box-based tumor localization. Subsequently, a multi-task network employed Feature-wise Linear Modulation (FiLM) to dynamically inject clinical metadata into the visual backbone. RESULTS: For histological subtyping of adenocarcinoma versus squamous cell carcinoma, in the validation cohort, the proposed multimodal framework achieved the highest area under the receiver operating characteristic curve (AUC) of 0.894 (95% CI: 0.813-0.959), significantly outperforming the conventional radiomics baseline (AUC = 0.796, DeLong test P = 0.017) and the clinical-only baseline (AUC = 0.759, P = 0.004). On the internal test set, the multimodal model maintained an AUC of 0.832 (95% CI: 0.744-0.906), outperforming competing models numerically, though differences did not reach statistical significance (all P > 0.11). On the independent external test cohort, the multimodal framework demonstrated superior cross-center stability, maintaining an AUC of 0.787 (95% CI: 0.687-0.876). On the external cohort, the between-model AUC differences did not reach statistical significance against the clinical-only model (AUC of 0.740, P = 0.480) or the image-only model (AUC of 0.685, P = 0.082). Nevertheless, the multimodal framework achieved the highest F1-score and yielded the most optimal net clinical benefit across a wide range of threshold probabilities in decision curve analysis. For the intrinsically challenging auxiliary staging task, the unguided image-only network exhibited severe vulnerability, however, the FiLM-based multimodal mechanism effectively enhanced diagnostic capacity by employing systemic clinical priors, improving the AUC to 0.656. CONCLUSION: Combining 3D detection with an early clinico-biological fusion strategy effectively enhances NSCLC characterization on [18F]FDG PET/CT, which has the potential to mitigate the limitations of single-modality imaging in resolving diagnostically ambiguous cases characterized by overlapping [18F]FDG uptake phenotypes, thereby providing a non-invasive decision-support tool in the precision management of NSCLC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungFluorodeoxyglucose F18Positron Emission Tomography Computed TomographyLung NeoplasmsDeep LearningImage Processing, Computer-AssistedHumansRadiomicsMaleFemale

Stichwörter der Autor:innen

Deep learningHistologic subtypeNSCLCRadiomics[18F]FDG PET/CT

Substanzen

Fluorodeoxyglucose F18

Autor:innen und Institutionen

  • Department of Clinical Engineering, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, 310009, China.
  • Institute of Nuclear Medicine and Molecular Imaging of Zhejiang University, Hangzhou, Zhejiang, 310009, China.
  • Key Laboratory of Medical Molecular Imaging of Zhejiang Province, Hangzhou, Zhejiang, 310009, China.
  • College of Biomedical Engineering & Instrument Science, Zhejiang University, Hangzhou, Zhejiang, 310027, China.
  • Department of Nuclear Medicine, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine, Chinese Academy of Sciences, Hangzhou, Zhejiang, 310022, China.
  • Key Laboratory for Biomedical Engineering of Ministry of Education, Zhejiang University, Hangzhou, Zhejiang, 310027, China.

ORCID-Profile: Hong Zhang

Förderung

  • Key Technologies Research and Development Program
  • National Natural Science Foundation of China

Zitieren

APA

Zhang, J., Zhang, X., Wang, J., Hao, H., Hu, D., Hu, K., Li, X., Li, Y., Liu, G., Tian, R., Wu, W., Ma, X., Huang, Y., Jin, C., Zhong, Y., Tian, M., & Zhang, H. (2026). Deep integration of clinical metadata with [18F]FDG PET/CT imaging for histological subtyping in non-small cell lung cancer: a multi-center study. European Journal of Nuclear Medicine and Molecular Imaging. https://doi.org/10.1007/s00259-026-08010-1

Vancouver

Zhang J, Zhang X, Wang J, Hao H, Hu D, Hu K, et al. Deep integration of clinical metadata with [18F]FDG PET/CT imaging for histological subtyping in non-small cell lung cancer: a multi-center study. European Journal of Nuclear Medicine and Molecular Imaging. 2026. doi:10.1007/s00259-026-08010-1

BibTeX
@article{Zhang2026,
  author = {Zhang, Jucheng and Zhang, Xiaohui and Wang, Jing and Hao, Han and Hu, Daoyan and Hu, Kangjun and Li, Xuena and Li, Yaming and Liu, Guanghui and Tian, Rong and Wu, Weiming and Ma, Xiaofen and Huang, Yile and Jin, Chentao and Zhong, Yan and Tian, Mei and Zhang, Hong},
  title = {Deep integration of clinical metadata with [18F]FDG PET/CT imaging for histological subtyping in non-small cell lung cancer: a multi-center study},
  journal = {European Journal of Nuclear Medicine and Molecular Imaging},
  year = {2026},
  doi = {10.1007/s00259-026-08010-1}
}
Kostenlos starten →